TY - JOUR
T1 - Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes
AU - Amon, Michael A.
AU - Ali, Marina
AU - Bender, Veronika
AU - Hall, Kristopher
AU - Aguilar, Marie-Isabel
AU - Aldrich-Wright, Janice
AU - Manolios, Nicholas
PY - 2008
Y1 - 2008
N2 - Core peptide (CP; GLRILLLKV) is a 9-amino acid peptide derived from the transmembrane sequence of the T-cell antigen receptor (TCR) α-subunit. CP inhibits T-cell activation both in vitro and in vivo by disruption of the TCR at the membrane level. To elucidate CP interactions with lipids, surface plasmon resonance (SPR) and circular dichroism [CD) were used to examine CP binding and secondary structure in the presence of either the anionic dimyristoyl-L-α-phosphatidyl-DL-glycerol (DMPG), or the zwitterionic dimyristoyl-L-α-phoshatidyl choline (DMPC). Using lipid monolayers and bilayers, SPR experiments demonstrated that irreversible peptide-lipid binding required the hydrophobic interior provided by a membrane bilayer. The importance of electrostatic interactions between CP and phospholipids was highlighted on lipid monolayers as CP bound reversibly to anionic DMPG monolayers, with no detectable binding observed on neutral DMPC monolayers. CD revealed a dose-dependent conformational change of CP from a dominantly random coil structure to that of β-structure as the concentration of lipid increased relative to CP. This occurred only in the presence of the anionic DMPG at a lipid : peptide molar ratio of 1.6:1 as no conformational change was observed when the zwitterionic DMPC was tested up to a lipid : peptide ratio of 8.4: 1.
AB - Core peptide (CP; GLRILLLKV) is a 9-amino acid peptide derived from the transmembrane sequence of the T-cell antigen receptor (TCR) α-subunit. CP inhibits T-cell activation both in vitro and in vivo by disruption of the TCR at the membrane level. To elucidate CP interactions with lipids, surface plasmon resonance (SPR) and circular dichroism [CD) were used to examine CP binding and secondary structure in the presence of either the anionic dimyristoyl-L-α-phosphatidyl-DL-glycerol (DMPG), or the zwitterionic dimyristoyl-L-α-phoshatidyl choline (DMPC). Using lipid monolayers and bilayers, SPR experiments demonstrated that irreversible peptide-lipid binding required the hydrophobic interior provided by a membrane bilayer. The importance of electrostatic interactions between CP and phospholipids was highlighted on lipid monolayers as CP bound reversibly to anionic DMPG monolayers, with no detectable binding observed on neutral DMPC monolayers. CD revealed a dose-dependent conformational change of CP from a dominantly random coil structure to that of β-structure as the concentration of lipid increased relative to CP. This occurred only in the presence of the anionic DMPG at a lipid : peptide molar ratio of 1.6:1 as no conformational change was observed when the zwitterionic DMPC was tested up to a lipid : peptide ratio of 8.4: 1.
UR - http://handle.uws.edu.au:8081/1959.7/555829
U2 - 10.1002/psc.987
DO - 10.1002/psc.987
M3 - Article
SN - 1075-2617
VL - 14
SP - 714
EP - 724
JO - Journal of Peptide Science
JF - Journal of Peptide Science
IS - 6
ER -